Entera Bio Ltd. (ENTX)
Nasdaq: ENTX · Biological Products, (No Diagnostic Substances) · Jerusalem · filing with the SEC since 2015
Income statement, as filed
In thousands of US dollars (USD), as filed; per-share figures in US dollars; share counts. The fiscal year ends in December.| Fiscal year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|---|
| Period ending | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 |
| Report filed | Mar 27, 2026 | Mar 28, 2025 | Mar 8, 2024 | Mar 31, 2023 | Mar 8, 2022 | Mar 18, 2021 | Mar 26, 2020 |
| Revenue | 42 | 181 | 0 | 134 | 571 | 365 | · |
| Cost of revenue | 42 | 172 | 0 | 101 | 373 | 300 | · |
| Gross profit | 0 | 9 | 0 | 33 | 198 | 65 | · |
| Research and development | 6,004 | 4,499 | 4,510 | 5,848 | 6,771 | 6,382 | · |
| Selling, general and administrative | 398 | 340 | · | · | · | · | · |
| General and administrative | 5,525 | 5,095 | 4,430 | 7,253 | 5,690 | 4,851 | · |
| Total operating expenses | 11,529 | 9,594 | 8,891 | 13,050 | 12,415 | 11,233 | · |
| Operating income | -11,529 | -9,585 | -8,891 | -13,017 | -12,217 | -11,168 | · |
| Total non-operating income (expense) | 90 | 58 | 31 | 83 | -29 | -28 | · |
| Income before income taxes | -11,439 | -9,527 | -8,860 | -12,934 | -12,246 | -11,196 | · |
| Income tax expense | 0 | 14 | 29 | 137 | -59 | 20 | · |
| Net income | -11,439 | -9,541 | -8,889 | -13,071 | -12,187 | -11,216 | · |
| Earnings per share, basic | 0.25 | 0.25 | 0.31 | 0.45 | 0.47 | · | · |
| Earnings per share, diluted | 0.25 | 0.25 | 0.31 | 0.45 | 0.47 | · | · |
| Earnings per share, basic and diluted | · | · | · | · | 0.47 | 0.67 | · |
| Weighted average shares, basic | 46,191,067 | 37,650,179 | 29,007,794 | 28,808,090 | 26,133,770 | · | · |
| Weighted average shares, diluted | 46,191,067 | 37,650,179 | 29,007,794 | 28,808,090 | 26,133,770 | · | · |
| Weighted average shares, basic and diluted | · | · | · | · | 26,133,770 | 18,417,093 | · |
As filed with the SEC, each figure from the newest report that carries it, and linked to it. Nothing here is computed.A dot is a line not tagged for that period. r restated by the company in a later report; b a share figure put on the newest basis or filed in the wrong unit. Hover a figure for its filing and note.
What each line is, and the XBRL concept behind it
Revenue what customers paid for what it sold
us-gaap:RevenuesCost of revenue what it cost to make or buy what it sold
us-gaap:CostOfRevenueGross profit revenue less the cost of what it sold
us-gaap:GrossProfitResearch and development spent on inventing what it sells next
us-gaap:ResearchAndDevelopmentExpenseSelling, general and administrative the cost of selling and of running the company
us-gaap:SellingGeneralAndAdministrativeExpenseGeneral and administrative the cost of running the company itself
us-gaap:GeneralAndAdministrativeExpenseTotal operating expenses the running costs together
us-gaap:OperatingExpensesOperating income profit from running the business, before interest and tax
us-gaap:OperatingIncomeLossTotal non-operating income (expense) everything outside the business, together
us-gaap:NonoperatingIncomeExpenseIncome before income taxes profit before tax
us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterestIncome tax expense tax charged on the period's profit
us-gaap:IncomeTaxExpenseBenefitNet income the profit or loss that belongs to the company's shareholders
us-gaap:NetIncomeLossEarnings per share, basic net income per share outstanding
us-gaap:EarningsPerShareBasicEarnings per share, diluted net income per share, counting every share that could be issued
us-gaap:EarningsPerShareDilutedEarnings per share, basic and diluted net income per share, where both counts are the same
us-gaap:EarningsPerShareBasicAndDilutedWeighted average shares, basic the average count of shares outstanding
us-gaap:WeightedAverageNumberOfSharesOutstandingBasicWeighted average shares, diluted the average count with every share that could be issued
us-gaap:WeightedAverageNumberOfDilutedSharesOutstandingWeighted average shares, basic and diluted the average count, where both counts are the same
us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted